Validated deeptechs with reduced risk and global potential
Converge Lab structures science-based startups with regulatory foundation, business thesis, and exit strategy from day one. We offer technically, legally, and institutionally mature projects for investors who want to combine return and impact.
Market Opportunity
Deeptech is one of the fastest-growing market — and the one that demands the most structure
Global Investment in Deeptech (2023)
Deficit in Scientific Projects
Our Model Reduces Investor Risk
We structure before raising so you can invest with confidence
Technical and regulatory validation
All projects undergo due diligence and alignment with national and international regulatory requirements — including ANVISA, INMETRO, NPL, FDA, EMA, among others.
Robust legal structure
Governance tools, shareholder agreements, and compliance in place from the start.
Defined exit strategy
We plan realistic paths to exit: M&A, corporate acquisition, or follow-on rounds.
Ready to invest?
We’re always open to conversations with funds, angel investors, corporate ventures, and family offices that share our vision: investing in science is investing in the future. Let’s schedule a meeting?